Get started
The-Trend-is-the-Friend

TEVA - Double Bottom?

Long
Teva Pharmaceutical Industries Limited (NYSE:TEVA)  
The-Trend-is-the-Friend  
NYSE:TEVA   Teva Pharmaceutical Industries Limited
Trend Analysis Fundamental Analysis Double Bottom fibonaccianalysis trend intrinsicvalue cashflow
2
2
trendanalysis fundamental doublebottom fibonaccianalysis trend intrinsicvalue cashflow
TEVA has been a repair story now for many years. With litigation in the process of being resolved, debt burdens of $2 bn. per year appear manageable with cash flow - TEVA is moving away from a debt/litigation story
to an equity story. Cash Flow of $3bn + per year, Net Income of ~ 2bn.+.... warrant a blended Intrinsic Value of ~ $22 per share. TEVA's technicals show a textbook double bottom with positive divergence. Reverting to trends and fibonacci levels confirm $22 target.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.